Summary
We studied the quantitative and qualitative characteristics of lipoprotein(a) [Lp(a)] as a function of apolipoprotein(a) [apo(a)] phenotype in 87 members (42 males, 45 females) of 20 diabetic families, 26 of whom were diagnosed with non-insulin-dependent diabetes mellitus (NIDDM) with moderate glycaemic control (HbA1c7.1±1.2%). Apo(a) phenotyping was performed by a sensitive, high-resolution technique using SDS-agarose/gradient PAGE (3–6%). To date, 26 different apo(a) phenotypes, including a null type, have been identified. Serum Lp(a) levels of NIDDM patients and non-diabetic members of the same family who had the same apo(a) phenotypes were compared, while case control subjects were chosen from high-Lp(a) non-diabetic and low-Lp(a) non-diabetic groups with the same apo(a) phenotypes in the same family. Serum Lp(a) levels were significantly higher in NIDDM patients than in non-diabetic subjects (39.8±33.3 vs 22.3±19.5 mg/dl, p<0.05). The difference in the mean Lp(a) level between the diabetic and non-diabetic groups was significantly (p<0.05) greater than that between the high-Lp(a) non-diabetic and low-Lp(a) non-diabetic groups. An analysis of covariance and a least square means comparison indicated that the regression line between serum Lp(a) levels [log Lp(a)] and apo(a) phenotypes in the diabetic patient group was significantly (p<0.01) elevated for each apo(a) phenotype, compared to the regression line of the control group. These data, together with our previous findings that serum Lp(a) levels are genetically controlled by apo(a) phenotypes, suggest that Lp(a) levels in diabetic patients are not regulated by smaller apo(a) isoforms, and that serum Lp(a) levels are greater in diabetic patients than in non-diabetic family members, even when they share the same apo(a) phenotypes.
Article PDF
Similar content being viewed by others
Abbreviations
- Lp(a):
-
Lipoprotein(a)
- apo(a):
-
apolipoprotein(a)
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- TC:
-
total cholesterol
- LDL:
-
low density lipoprotein
- TG:
-
triglycerides
- HDL-C:
-
high density lipoprotein-cholesterol
- LDL-C:
-
low density lipoprotein-cholesterol
- PBS:
-
phosphate buffered saline
References
Berg KI (1963) A new serum type system in man — the Lp system. Acta Pathol Microbiol Immunol Scand 59: 369–382
Fless GM, ZumMallen ME, Scanu AM (1985) Isolation of apolipoprotein(a) from lipoprotein(a). J Lipid Res 26: 1224–1229
Fless GM, ZumMallen ME, Scanu AM (1986) Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein(a). J Biol Chem 261: 8712–8718
Mbewu AD, Durrington PN (1990) Lipoprotein(a): structure, properties and possible involvement in thrombogenesis and atherogenesis. Atherosclerosis 85: 1–14
McLean JW, Tomlinson JE, Kuang WJ et al. (1989) cDNA sequence of human apolipoprotein(a) is homologue to plasminogen. Nature 330: 132–137
Utermann G (1989) The mysteries of lipoprotein(a). Science 246: 904–910
Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH (1992) Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 90: 52–60
Gaubatz JW, Ghanem KI, Guevara JJ, Nava ML, Patsch W, Morrisett JD (1990) Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a]. J Lipid Res 31: 603–613
Kamboh MI, Ferrell RE, Kottke BA (1991) Expressed hypervariable polymorphism of apolipoprotein(a). Am J Hum Genet 49: 1063–1074
Cohen JC, Chiesa G, Hobbs HH (1993) Sequence polymorphisms in the apolipoprotein(a) gene; evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest 91: 1630–1636
Gavish D, Azrolan N, Breslow L (1989) Plasma Lp(a) concentration is inversely correlated with the ratio of kringle IV/kringle V encoding domains in the apo(a) gene. J Clin Invest 84: 2021–2027
Kikuchi S, Nakagawa A, Kobayashi K et al. (1993) High degree of genetic polymorphism in apolipoprotein(a) associated with plasma lipoprotein(a) levels in Japanese and Chinese populations. Hum Genet 92: 537–544
Hirata K, Kikuchi S, Saku K et al. (1993) Apolipoprotein(a) phenotypes and serum lipoprotein(a) levels in maintenance hemodialysis patients with/without diabetes mellitus. Kidney Int 44: 1062–1070
Dahlen GH, Guyton JR, Arrar M, Farmer JA, Kaut JA, Gotto AM Jr (1986) Association of level of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74: 758–768
Rhoads GG, Dahlen G, Berg K, Morton NE, Dannenberg AL (1986) Lp(a) lipoprotein as a risk factor for myocardial infarction. J Am Med Assoc 256: 2540–2544
Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M (1986) Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 59: 199–204
Armstrong VW, Cremer P, Eberle E et al. (1986) The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Atherosclerosis 62: 249–257
Sandholzer C, Saha N, Kark JD et al. (1992) Apo(a) isoforms predict risk for coronary heart disease. A study in six populations. Arterioscler Thromb 12: 1214–1226
Koistinen MJ (1990) Prevalence of asymptomatic myocardial ischemia in diabetic subjects. BMJ 301: 92–95
Utermann G, Duba C, Menzel HJ (1988) Genetics of the quantitative Lp(a) lipoprotein trait. II. Inheritance of Lp(a) glycoprotein phenotypes. Hum Genet 78: 47–50
Lackner C, Boerwinkle E, Leffert CC, Rahmig T, Hobbs HH (1991) Molecular basis of apolipoprotein(a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest 87: 2153–2161
Yanagi H, Nakagawa A, Kikuchi S et al. (1993) Frequent occurrence of familial aggregations of high lipoprotein(a) levels associated with small apolipoprotein(a) isoforms. Hum Genet 92: 545–548
Allain CC, Poon LS, Chan CS (1974) Enzymatic determination of total cholesterol. Clin Chem 20: 470–475
Eggestein M, Kreuntz FH (1966) Eine neue Bestimmung der Neutralfette in Blutserum und Gewebe, Prinzip, Durchführung und Besprechung der Methode. Klin Wochenschr 44: 262
Noma A, Nezu-Nakayama K, Kita M, Okabe H (1978) Simultaneous determination of serum cholesterol in high and low-density lipoproteins with use of heparin Ca2+, and anion-exchange resin. Clin Chem 24: 1504–1508
Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499–502
Havel RL, Eder HA, Bragton JH (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345–1353
Ikeda T, Shibuya U, Sugiuchi H, Araki S, Uji Y, Okabe H (1991) Automated immunoturbidimetric analysis of six plasma apolipoproteins: correlation with radial immunodiffusion assays. J Clin Lab Anal 5: 90–95
Abe A, Maeda S, Makino K et al. (1988) Enzyme-linked immunosorbent assay of lipoprotein(a) in serum and cord blood. Clin Chim Acta 177: 31–40
Mogan CR, Lazarow A (1963) Immunoassay of insulin: two antibody system. Diabetes 12: 115–126
Haffner SM, Tuttle KR, Rainwater DL (1992) Lack of change of lipoprotein(a) with improved glycemic control in subjects with type II diabetes. Metabolism 41: 116–120
Jenkins AJ, Steele JS, Janus ED, Santamaria JD, Best JD (1992) Plasma apolipoprotein(a) is increased in type 2 (non-insulin-dependent) diabetic patients with microalbuminuria. Diabetologia 35: 1055–1059
Takegoshi T, Haba T, Hirai J et al. (1990) Alterations of lipoprotein(a) in patients with diabetic nephropathy. Atherosclerosis 83: 99–100
Wanner C, Rader D, Bartens W et al. (1993) Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome. Ann Intern Med 119: 263–269
Nielsen FS, Voldsgard AI, Gall M-A et al. (1993) Apolipoprotein(a) and cardiovascular disease in type 2 (non-insulin-dependent) diabetic patients with and without diabetic nephropathy. Diabetologia 36: 438–444
Dubrey SW, Reaveley DA, Leslie DG et al. (1993) Effect of insulin-dependent diabetes mellitus on lipids and lipoproteins: a study of identical twins. Clin Sci 84: 537–542
Heesen BJ, Wolffenbuttel BHR, Leurs PB et al. (1993) Lipoprotein(a) levels in relation to diabetic complications in patients with non-insulin-dependent diabetes. Eur J Clin Invest 23: 580–584
Maioli M, Tonolo G, Pacifico A et al. (1993) Raised serum apolipoprotein(a) in active diabetic retinopathy. Diabetologia 36: 88–90
Bruckert E, Davidoff P, Grimaldi A et al. (1990) Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control. JAMA 263: 35–36
Boomsma DI, Kaptein A, Kempen HJM, Leuven JAG, Princen HMG (1993) Lipoprotein(a): relation to other risk factors and genetic heritability. Results from a Dutch parent-twin study. Atherosclerosis 99: 23–33
Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Scitz C (1987) Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a) lipoprotein concentrations in plasma. J Clin Invest 80: 458–465
Jenner JL, Ordovas JM, Lamon-Fava S et al. (1993) Effect of age, sex, and menopausal status on plasma lipoprotein(a) levels. The Framingham offspring study. Circulation 87: 1135–1141
Cohn JS, Lam CWK, Sullivan DR, Hensley WJ (1991) Plasma lipoprotein distribution of apolipoprotein(a) in the fed and fasted states. Atherosclerosis 90: 59–66
Okura Y, Saku K, Hirata K et al. (1993) Serum lipoprotein(a) levels in maintenance hemodialysis patients. Nephron 65: 46–50
Rader DJ, Cain W, Zech LA, Usher D, Brewer HB Jr (1993) Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest 91: 443–447
Csaszar A, Dieplinger H, Sandholzer C et al. (1993) Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus. Diabetologia 36: 47–51
Author information
Authors and Affiliations
Additional information
The first two authors contributed equally to this work
Rights and permissions
About this article
Cite this article
Hirata, K., Saku, K., Jimi, S. et al. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in the families of NIDDM patients. Diabetologia 38, 1434–1442 (1995). https://doi.org/10.1007/BF00400604
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00400604